ScoreWhy is Valiant Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 14.20% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.65
2
With ROE of -1.1, it has a Very Expensive valuation with a 1.3 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -29.58%, its profits have fallen by -49.1%
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -1.52% in the last 1 year, its fall in the stock was much higher with a return of -29.58%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Valiant Laborato for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Valiant Laborato
-29.58%
-0.55
53.57%
Sensex
-7.92%
-0.61
13.09%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.20%
EBIT Growth (5y)
42.58%
EBIT to Interest (avg)
-5.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
0.68
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
-0.58%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.32
EV to EBIT
423.12
EV to EBITDA
66.32
EV to Capital Employed
1.31
EV to Sales
1.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.10%
ROE (Latest)
-1.06%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
PAT(Q)
At Rs 1.76 cr has Grown at 262.2% (vs previous 4Q average
NET SALES(Q)
Highest at Rs 91.98 cr
PBDIT(Q)
Highest at Rs 4.81 cr.
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Valiant Laborato
Net Sales - Quarterly
At Rs 91.98 cr has Grown at 81.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 50.82 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 1.76 cr has Grown at 262.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -1.09 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 91.98 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 4.81 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
